β2-MICROGLOBULIN-ASSOCIATED AMYLOIDOSIS IN CHRONIC HAEMODIALYSIS PATIENTS
- 24 May 1986
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 327 (8491), 1212
- https://doi.org/10.1016/s0140-6736(86)91190-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- Destructive spondylarthropathy in hemodialyzed patients: Possible role of amyloidosisArthritis & Rheumatism, 1986
- Beta-2 microglobulin is an amyloidogenic protein in man.Journal of Clinical Investigation, 1985
- Synovial amyloidosis in patients undergoing long‐term hemodialysisArthritis & Rheumatism, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Elimination of Low Molecular Weight Proteins with High Flux Membranes1Published by S. Karger AG ,1984
- Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranesKidney International, 1983
- Plasma β2, Microglobulin Turnover in Renal InsufficiencyActa Clinica Belgica, 1980
- Serum β2-Microglobulin in Hemodialyzed PatientsNephron, 1978